Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation

Denzen, Ellen M.; Preussler, Jaime M.; Murphy, Elizabeth A.; Baker, K. Scott; Burns, Linda J.; Foster, Jackie; Idossa, Lensa; Moore, Heather; Payton, Tammy; Haven, Darlene; Jahagirdar, Balkrishna; Kamani, Naynesh; Rizzo, J. Douglas; Salazar, Lizette; Schatz, Barry A.; Syrjala, Karen L.; Wingard, John R.; Majhail, Navneet S.

doi:10.1016/j.bbmt.2018.10.005

Cited by 17 publications

(17 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…43,44 Centers can use guidelines for long-term followup and tools such as treatment summary and survivorship care plans to establish a foundation for coordinated patient-centric survivorship care. [44][45][46][47][48] Our study has the limitations of an observational registry based analysis. In addition, we did not take into account autologous HCT experience and volumes, since reporting of autologous HCT activity is voluntary and is not included in the annual center survival analysis.…”

Section: Discussionmentioning

confidence: 96%

Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults

Majhail

Mau

Chitphakdithai

et al. 2019

Bone Marrow Transplant

Self Cite

View full text Add to dashboard Cite

Allogeneic hematopoietic cell transplantation (alloHCT) is a highly specialized procedure. We surveyed adult transplant centers in the United States (US) and then used data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) (2008-2010) to evaluate associations of center volume, infrastructure, and care delivery models with survival post Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:

show abstract

Section: Discussionmentioning

confidence: 96%

Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults

Majhail

Mau

Chitphakdithai

et al. 2019

Bone Marrow Transplant

Self Cite

View full text Add to dashboard Cite

show abstract

“…Potentially eligible patients from 17 participating US centers were identified from the CIBMTR database, and paper-based SCPs personalized to HCT specific exposures were generated using CIBMTR data for patients who consented and enrolled on the study (see Online Supplementary Methods ). 43 Patient eligibility criteria were kept broad and included patients who were 1-5 years post transplant, ≥18 years at the time of HCT, with no evidence of disease relapse/progression or second cancers, and fluency in English; patients were eligible irrespective of transplant type (autologous or allogeneic), diagnosis, donor source or conditioning regimen. None of the participating centers had an existing mechanism for routinely providing SCPs to their patients.…”

Section: Methodsmentioning

confidence: 99%

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

et al. 2018

Self Cite

View full text Add to dashboard Cite

Survivorship Care Plans (SCPs) may facilitate long-term care for cancer survivors, but their effectiveness has not been established in hematopoietic cell transplantation recipients. We evaluated the impact of individualized SCPs on patient-reported outcomes among transplant survivors. Adult (≥18 years at transplant) survivors who were 1-5 years post transplantation, proficient in English, and without relapse or secondary cancers were eligible for this multicenter randomized trial. SCPs were developed based on risk-factors and treatment exposures using patient data routinely submitted by transplant centers to the Center for International Blood and Marrow Transplant Research and published guidelines for long-term follow up of transplant survivors. Phone surveys assessing patient-reported outcomes were conducted at baseline and at 6 months. The primary end point was confidence in survivorship information, and secondary end points included cancer and treatment distress, knowledge of transplant exposures, health care utilization, and health-related quality of life. Of 495 patients enrolled, 458 completed a baseline survey and were randomized (care plan=231, standard care=227); 200 (87%) and 199 (88%) completed the 6-month assessments, respectively. Patients’ characteristics were similar in the two arms. Participants on the care plan arm reported significantly lower distress scores at 6 months and an increase in the Mental Component Summary quality of life score assessed by the Short Form 12 (SF-12) instrument. No effect was observed on the end point of confidence in survivorship information or other secondary outcomes. Provision of individualized SCPs generated using registry data was associated with reduced distress and improved mental domain of quality of life among 1-5 year hematopoietic cell transplantation survivors. Trial registered at clinicaltrials.gov 02200133 .

show abstract

“…Screening rec om men da tions and pos si ble man age ment options may also be incor po rated into sur vi vor ship care sum ma ries to facil i tate the deliv ery of psycho so cial care across the tra jec tory of HCT care. 38 It is inter esting to note that these indi vid u al ized care plans as edu ca tional tools can lead to reduced dis tress and improve ment in the mental domain of health-related qual ity of life, as shown by a recent ran dom ized clin i cal trial. 39…”

Section: Screening For and Inter Ven Tions To Help Improve Psy Cho So Cial Health In Hct Sur VI Vorsmentioning

confidence: 99%

Psychosocial and financial issues after hematopoietic cell transplantation

Buchbinder

Khera

2021

Hematology

View full text Add to dashboard Cite

With improvement in survival after hematopoietic cell transplantation (HCT), it has become important to focus on survivors' psychosocial issues in order to provide patient-centered care across the transplant continuum. The goals of this article are to describe updates in the literature on certain psychosocial domains (emotional/mental health and social/financial) in HCT survivors, offer a brief overview of the status of the screening and management of these complications, and identify opportunities for future practice and research. An evidence-based approach to psychosocial care can be broken down as primary (promoting health, raising awareness, and addressing risk factors), secondary (screening and directing early pharmacological and nonpharmacological interventions), and tertiary (rehabilitating, limiting disability, and improving quality of life) prevention. Implementing such an approach requires close coordination between multiple stakeholders, including transplant center staff, referring hematologist/oncologists, and other subspecialists in areas such as palliative medicine or psychiatry. Innovative models of care that leverage technology can bring these stakeholders together to fulfill unmet needs in this area by addressing barriers in the delivery of psychosocial care.

show abstract

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation

Cited by 17 publications

References 31 publications

Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults

Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

Psychosocial and financial issues after hematopoietic cell transplantation

Contact Info

Product

Resources

About